Evidence map›Paper›PMID 39670186›Full record

ArticleHemaSphere2024

Analysis of smoldering multiple myeloma according to the target of the monoclonal immunoglobulin of patients.

Sylvie Hermouet, Nicolas Mennesson, Sophie Allain-Maillet, Edith Bigot-Corbel, Andri Olafsson, Brynjar Viðarsson, Páll T Önundarson, Bjarni A Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Sylvie HermouetNantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302 Nantes France.ORCID 0000-0001-5444-4406
Nicolas MennessonNantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302 Nantes France.
Sophie Allain-MailletNantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302 Nantes France.
Edith Bigot-CorbelNantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302 Nantes France.
Andri OlafssonFaculty of Medicine University of Iceland Reykjavik Iceland.
Brynjar ViðarssonLandspitali-The National University Hospital of Iceland Reykjavik Iceland.
Páll T ÖnundarsonFaculty of Medicine University of Iceland Reykjavik Iceland.
Bjarni A AgnarssonFaculty of Medicine University of Iceland Reykjavik Iceland.
Margrét SigurðardóttirLandspitali-The National University Hospital of Iceland Reykjavik Iceland.
Ingunn ÞorsteinsdóttirLandspitali-The National University Hospital of Iceland Reykjavik Iceland.
Ísleifur ÓlafssonFaculty of Medicine University of Iceland Reykjavik Iceland.
Elías EyþórssonLandspitali-The National University Hospital of Iceland Reykjavik Iceland.
Ásbjörn JónssonAkureyri Hospital Akureyri Iceland.
Thorvardur J LoveFaculty of Medicine University of Iceland Reykjavik Iceland.
Saemundur RognvaldssonFaculty of Medicine University of Iceland Reykjavik Iceland.ORCID 0000-0003-2162-8414
Einar S BjörnssonFaculty of Medicine University of Iceland Reykjavik Iceland.
Sigrún ThorsteinsdóttirFaculty of Medicine University of Iceland Reykjavik Iceland.
Sigurdur Y KristinssonFaculty of Medicine University of Iceland Reykjavik Iceland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39670186
PMCPMC11635023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.